Recombinant antigens based on toxins A and B of Clostridium difficile that evoke a potent toxin-neutralising immune response.
about
A chimeric protein comprising the glucosyltransferase and cysteine proteinase domains of toxin B and the receptor binding domain of toxin A induces protective immunity against Clostridium difficile infection in mice and hamsters.The baculovirus expression vector system: A commercial manufacturing platform for viral vaccines and gene therapy vectors.Immunization with Recombinant TcdB-Encapsulated Nanocomplex Induces Protection against Clostridium difficile Challenge in a Mouse Model.Therapy for Clostridium difficile infection - any news beyond Metronidazole and Vancomycin?Novel Chimeric Protein Vaccines Against Infection
P2860
Recombinant antigens based on toxins A and B of Clostridium difficile that evoke a potent toxin-neutralising immune response.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Recombinant antigens based on ...... -neutralising immune response.
@en
Recombinant antigens based on ...... -neutralising immune response.
@nl
type
label
Recombinant antigens based on ...... -neutralising immune response.
@en
Recombinant antigens based on ...... -neutralising immune response.
@nl
prefLabel
Recombinant antigens based on ...... -neutralising immune response.
@en
Recombinant antigens based on ...... -neutralising immune response.
@nl
P2093
P2860
P1433
P1476
Recombinant antigens based on ...... -neutralising immune response.
@en
P2093
April Roberts
Clifford Shone
Harriet Denton
Helen Ahern
Joanna McGlashan
John Landon
Michael Maynard-Smith
Philip Nugent
Roger Ling
Ruth Coxon
P2860
P304
P356
10.1016/J.VACCINE.2013.11.099
P407
P577
2013-12-14T00:00:00Z